pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·6h ago·1 min read
save

Psilocybin proves promising in neuropathic pain mouse study

Sep 3, 2026·read at Fierce Biotech ↗

Amid the rise of psychedelics in the mental health space, researchers have begun to explore psilocybin as a treatment for chemotherapy-induced peripheral neuropathy.

source

Reporting by Fierce Biotech.

read at Fierce Biotech ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 6h agoPfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ dealFierce Biotech
  • 9h agoAbbVie’s bispecific T-cell engager shows promise in ph. 3 multiple myeloma trialFierce Biotech
  • 13h agoGSK pens $1.3B Hutchmed deal for early-stage KRAS-EGFR cancer assetFierce Biotech
  • 15h agoUltragenyx fails phase 3 Angelman test, plots ‘significant expense reductions’Fierce Biotech
  • 1d agoFortrea boosts early-phase CRO platform with $45M acquisition of Worldwide divisionFierce Biotech